Literature DB >> 2898375

Selectivity of ligand binding to opioid receptors in brain membranes from the rat, monkey and guinea pig.

M J Clark1, B D Carter, F Medzihradsky.   

Abstract

Conditions for the equilibrium binding to opioid receptor of [3H]sufentanil (mu selective), [3H][D-Pen2,D-Pen5]enkephalin (delta selective), and [3H]U69,593 (kappa selective) were established in membranes from rat brain cerebrum, monkey cortex, or guinea pig cerebellum. The selectivity index of various opioid alkaloids and peptides in binding to the mu, delta, or kappa opioid receptors was expressed as the ratio of their EC50 values in displacing two selective radiolabeled ligands: [3H]sufentanil/[3H](D-Pen2,D-Pen5)enkephalin (selectivity: mu/delta), [3H]sufentanil/[3H]U69,593 (selectivity: mu/kappa), or [3H][D-Pen2,D-Pen5]enkephalin/[3H]U69,593 (selectivity: delta/kappa). High resolution in binding selectivity was observed: in rat brain the mu/delta selectivity for Tyr-D-Ala-Gly-(Me)Phe-Gly-ol and sufentanil were 0.02 and 0.03, whereas for [D-Pen2,D-Pen5]enkephalin and ICI 174,864 they were 1,200 and 998. Compared to mu opiates, the specific binding of delta and kappa agonists was less sensitive to sodium. The results describe a routinely applicable methodological approach for the assessment of selective ligand binding to the mu, delta and kappa opioid receptors in rodent and monkey brain membranes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898375     DOI: 10.1016/0014-2999(88)90112-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Reconstitution of high-affinity opioid agonist binding in brain membranes.

Authors:  A E Remmers; F Medzihradsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.

Authors:  A H Mulder; D M Burger; G Wardeh; F Hogenboom; A L Frankhuyzen
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

3.  Computer-aided structure-affinity relationships in a set of piperazine and 3,8-diazabicyclo[3.2.1]octane derivatives binding to the mu-opioid receptor.

Authors:  D Barlocco; G Cignarella; G Greco; E Novellino
Journal:  J Comput Aided Mol Des       Date:  1993-10       Impact factor: 3.686

4.  Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.

Authors:  B D Carter; F Medzihradsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Regional cerebral glucose utilization in withdrawal following systemic and intracerebroventricular sufentanil administration.

Authors:  R E Adams; G F Wooten
Journal:  Neurochem Res       Date:  1994-10       Impact factor: 3.996

6.  Opioid receptors and myocardial protection: do opioid agonists possess cardioprotective effects?

Authors:  K J McCormack; C B Chapleo
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

7.  Oxytocin-Motivated Ally Selection is Moderated by Fetal Testosterone Exposure and Empathic Concern.

Authors:  Mariska E Kret; Carsten K W De Dreu
Journal:  Front Neurosci       Date:  2013-01-30       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.